Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPD-PA01 phage cocktail for multidrug-resistant Pseudomonas aeruginosa wound infections (Phase I/II)
ChiCTR2400084025Phase 2Not yet recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- May 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of CPD-PA01 in Wound infection (WI) (3 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoint: Clearance of Pseudomonas aeruginosa. Planned start May 2024; status: not yet recruiting.
02
Drugs
CPD-PA01
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on ChiCTR2400084025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400084025.